Skip to main content
Core Laboratories Inc. /DE/ logo

Core Laboratories Inc. /DE/ — Investor Relations & Filings

Ticker · CLB LEI · 984500040P5J07V43135 US Mining and quarrying
Filings indexed 182 across all filing types
Latest filing 2026-05-15 Regulatory Filings
Country US United States of America
Listing US CLB

About Core Laboratories Inc. /DE/

https://www.corelab.com/

Core Laboratories is a leading provider of proprietary and patented reservoir description and production enhancement services and products. The company enables its clients, which include major, national, and independent oil companies, to optimize reservoir performance and maximize hydrocarbon recovery. Its core activities involve the detailed analysis of reservoir rocks and fluids (crude oil, natural gas, and water) to generate critical data for exploration and production decisions. Key services include advanced core and fluid analysis, digital rock characterization, and AI-powered data tools. The production enhancement segment offers solutions such as tracer diagnostics for well spacing optimization and specialized testing to improve hydraulic fracturing outcomes. The company also leverages its expertise to provide subsurface characterization and monitoring for Carbon Capture and Storage (CCS) projects.

Recent filings

Filing Released Lang Actions
SD
Regulatory Filings Classification · 80% confidence The document is an SEC Form SD – a Specialized Disclosure Report under Rule 13p-1 for conflict minerals. It is a regulatory compliance filing (not an annual or quarterly financial report, not a proxy or governance statement, not a dividend or capital action). It does not present full financial statements or earnings highlights, nor is it a management or audit report. It is a mandatory SEC disclosure and does not fit any other specific category, so it falls under Regulatory Filings (RNS).
2026-05-15 English
8-K - Core Laboratories Inc. /DE/ (0001958086) (Filer)
Earnings Release Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated March 23, 2026, by Core Laboratories Inc. It announces a press release revising previously issued earnings guidance for Q1 2026. The text explicitly states that the press release is attached as Exhibit 99.1 and that the information is furnished, not filed, indicating this is an announcement rather than a full earnings report. The document length is 3417 characters, which is relatively short and consistent with a regulatory announcement rather than a full financial report. The content focuses on disclosure of updated earnings guidance, which aligns with an Earnings Release (ER) type document. Therefore, the classification is Earnings Release (ER) with high confidence.
2026-03-23 English
8-K/A - Core Laboratories Inc. /DE/ (0001958086) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K/A filed with the SEC, which is an amended current report. It specifically amends a previously filed Form 8-K that included an earnings release for the quarter and year ended December 31, 2025. The amendment corrects certain financial information related to income tax expenses and balance sheet items. The document is not the original earnings release but an amendment to it, providing revised financial details. It is not a full annual report (10-K), nor a management discussion, nor a call transcript. It is a regulatory filing that updates previously reported financial results and corrects errors. Given the nature of the document as an amended current report correcting financial data, the most appropriate classification is Regulatory Filings (RNS).
2026-03-17 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English
4 Filing
Director's Dealing
2026-02-17 English
4 Filing
Director's Dealing
2026-02-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.